Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
After the first 100 blogs, it is appropriate to reflect on reader preferences. When I arbitrarily select a topic, it is not always clear whether what interests me also interests you. Since its start 1½ years ago, this blog has grown Continue reading ALLPHASE PHARMA – THE FIRST 100 BLOG POSTS
There are currently a total of 6 beta-lactam + beta-lactamase inhibitor combinations in clinical trials. It will be a steep learning curve for the pharma reps (and physicians) to understand the resistance classifications, the confusing ESBL definitions, the CRE nomenclature, Continue reading What is the “Niche” for Ceftolozane / Tazobactam?
For the latest QIDP listing, please click HERE Since FDA issued the QIDP designation in 2012, many companies have requested this important ‘label’. Which should not come as a surprise: QIDP status confers significant benefits – and there is no Continue reading Antibiotics with QIDP Designation – – – Updated 9-30-14